Niki BioSolutions NIKI
NASDAQ NIKI
$4.81 +0.07 (+1.48%)
As of: Sep 30, 2026 · 9:42 AM EDT

Niki BioSolutions, Inc. (NIKI) EBIT Margin (2024 - 2025)

Updated

Niki BioSolutions (NIKI) reported EBIT Margin of -293.17% for FY2025.

Analysis

Niki BioSolutions, Inc. (NIKI) EBIT Margin (2024 - 2025) Analysis & Trends

Dating back to FY2022, Niki BioSolutions' EBIT Margin record includes 4 years.

  • EBIT Margin has a three-year change of -1750.47 percentage points (FY2022 to FY2025).
  • According to Business Quant data, EBIT Margin came in at -34.21% in FY2024, 2588.49% in FY2023 (+1131.19 pp) and 1457.31% in FY2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -575.40%
Nov 30, 2024 -35.35%
Aug 31, 2024 -71.86%
API Access

Niki BioSolutions, Inc. EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NIKI&period=max&api_key=YOUR_API_KEY